Catalyst Financial Partners LLC Cuts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Catalyst Financial Partners LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 7.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 821 shares of the company’s stock after selling 63 shares during the period. Catalyst Financial Partners LLC’s holdings in HCA Healthcare were worth $334,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Bangor Savings Bank boosted its stake in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $28,000. GPS Wealth Strategies Group LLC raised its stake in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $358.57 on Friday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a one year low of $223.73 and a one year high of $417.14. The company has a market cap of $92.54 billion, a P/E ratio of 16.10, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The business has a fifty day moving average of $393.62 and a two-hundred day moving average of $353.85.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCA. Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Leerink Partners lifted their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $379.11.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.